Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-25 @ 1:33 AM
NCT ID:
NCT00002894
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Ovarian epithelial cancer or serous peritoneal carcinoma that has relapsed after prior chemotherapy
* Progression-free interval (from end of last treatment) of at least 6 months
* Measurable disease not required
PATIENT CHARACTERISTICS:
Age:
* Not specified
Performance status:
* Not specified
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Bilirubin less than 2 times normal
Renal:
* Not specified
Other:
* No sepsis
* No contraindication to chemotherapy
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* See Disease Characteristics
Endocrine therapy
* Not specified
Radiotherapy
* Not specified
Surgery
* Not specified
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT00002894
Study Brief:
Protocol Section:
NCT00002894